Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Drug Eluting Stent Market Growth Evolved From 2024 To 2025, And What’s Ahead?

In recent years, the market size for drug eluting stents has seen robust growth. It’s projected that this market will expand from $7.63 billion in 2024 to $8.26 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%. The growth observed in the historical period can be ascribed to several factors such as the need for better treatment alternatives, clinical proof, healthcare economics, regulatory approval, and pertinent guidelines and recommendations.

The market for drug eluting stents is anticipated to witness robust expansion in the forthcoming years, and it is predicted to reach a valuation of $11.07 billion in 2029 with a CAGR of 7.6%. Factors driving this growth in the predicted period include the increasing aging population and burden of chronic diseases, broadening of indications, changes in healthcare reimbursement policies, expansion of the global market, and focus on patient-oriented care. Key trends during this projected period involve bespoke medicine, less intrusive procedures, emerging medical technologies, and innovative drug compounds.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15557&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Drug Eluting Stent Market?

The escalating issue of coronary heart disease is anticipated to drive the expansion of the drug-eluting stent market in the future. Coronary heart disease (CHD), a situation where the coronary arteries become obstructed or narrow due to plaque accumulation, can lead to severe health complications, such as chest pain or a heart attack. This disease is on the rise due to factors such as inactive lifestyles, inadequate diets, aging demographics, and increased general awareness. Drug-eluting stents (DES) offer significant benefits for coronary heart disease sufferers by effectively clearing blocked or narrow coronary arteries and discharging medication that curbs re-narrowing (restenosis) of the artery. For example, the Centers for Disease Control and Prevention, a government organization based in the US, reported in May 2024 that the prevalence of coronary heart disease in adults aged 18 and above went from 4.6% in 2020 to 4.9% in 2022. This escalating prevalence of coronary heart disease is anticipated to fuel the expansion of the drug-eluting stent market.

Which Primary Segments of the Drug Eluting Stent Market Are Driving Growth and Industry Transformations?

The drug eluting stentmarket covered in this report is segmented –

1) By Product: Polymer-Based, Polymer-Free

2) By Drug: Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Other Drugs

3) By Scaffold: Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Other Scaffolds

4) By Application: Coronary Diseases, Peripheral Vascular Diseases

5) By End-User: Hospitals, Specialty Clinic

Subsegments:

1) By Polymer-Based: Durable Polymer Drug-Eluting Stents, Biodegradable Polymer Drug-Eluting Stents

2) By Polymer-Free: Bare-Metal Stents With Drug Coating, Other Polymer-Free Drug-Eluting Stents

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15557&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Drug Eluting Stent Market?# Market?

North America was the largest region in the drug-eluting stent market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Drug Eluting Stent Market?

In the drug-eluting stent market, businesses are channeling their energies into the creation of unique delivery techniques, such as the innovative dual-layer balloon, aiming to improve patient results and contribute to the progress of interventional cardiology. The incorporation of a dual-layer balloon in a drug-eluting stent system contributes to more precise drug administration and stent positioning by augmenting control and ensuring uniform drug diffusion to the arterial wall. As an illustration, in August 2022, Medtronic Plc, an Irish firm specialized in medical supplies, introduced Onyx Frontier, the newest iteration of drug-eluting coronary stent systems. These are engineered to improve delivery systems, building on the acute performance and clinical findings from the previous Resolute Onyx DES version. The Onyx Frontier DES utilizes the same top-of-the-line stent platform as Resolute Onyx, offering a wide size matrix accommodating patients with diameters from 2.0mm to 5.0mm. The design of the Onyx Frontier DES includes exceptional advancements such as an innovative dual-layer balloon, decreased crossing profile, and enhanced catheter flexibility. These enhancements result in a 16% improvement in deliverability compared to the former Resolute Onyx DES series, while maintaining radial strength.

View the full report here:

https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report

What Parameters Are Used to Define the Drug Eluting Stent Market?

A drug-eluting stent (DES) is a medical device used in the treatment of coronary artery disease (CAD). It is a small, mesh-like tube typically made of metal that is inserted into narrowed or blocked coronary arteries during a procedure called percutaneous coronary intervention (PCI) or angioplasty.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15557

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model